NASDAQ:GLSI

Greenwich Lifesciences Stock Predictions

Healthcare > Biotechnology

Buy GLSI

*Your capital is at risk

$24.29

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

GLSI Prediction Chart

GLSI Predictions History

Latest community submissions for GLSI.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jun 21, 2021	$35.49 -3.93%	$36.94	X	96.07%	0
Seviris	Jun 21, 2021	Bearish	$36.94	X	—	1
JS Pro	Dec 21, 2020	$42.12 +14.61%	$36.75	X	85.39%	0
JOAO181955	Dec 18, 2020	Bearish	$38.22	X	—	1
JS Pro	Dec 10, 2020	$48.65 -32.64%	$72.22	X	67.36%	0
Solids Metallurgy @SolidsMetallurgy.178054	Dec 10, 2020	Bearish	$72.22	X	—	0
Ann181337	Dec 10, 2020	Bullish	$72.22	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GLSI with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GREENWICH LIFESCIENCES, INC.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name t...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by